Sign Up to like & get
recommendations!
0
Published in 2019 at "Hematology/oncology clinics of North America"
DOI: 10.1016/j.hoc.2019.04.002
Abstract: Therapeutic advances for peripheral T-cell non-Hodgkin lymphoma (PTCL) have lagged behind their B-cell NHL counterparts in part because novel agents to treat PTCL have been developed empirically. The recent clinical success of brentuximab-vedotin suggests that…
read more here.
Keywords:
cell lymphoma;
peripheral cell;
cell;
toward targeted ... See more keywords